The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:1642-a, September 2006
doi: 10.1176/appi.ajp.163.9.1642-a
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by MATTES, J. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by MATTES, J. A.
Related Collections
* Other Mood Disorders
* Antidepressants

Letter to the Editor

Less Mood Switching With Venlafaxine?

JEFFREY A. MATTES, M.D.
Princeton, N.J.

To the Editor: I’m writing in response to the recent article by Gabriele S. Leverich, M.S.W., L.C.S.W.-C., and colleagues regarding mood switches.

If the rate of threshold switches was not different between bupropion, sertraline, and venlafaxine, then the marked difference (between the three drugs) in the ratio between threshold and subthreshold switches must be because of the fact that there were fewer subthreshold switches with venlafaxine. There is some theoretical rationale for thinking that venlafaxine might be more likely to induce switches, but the fact that there were less subthreshold switches with venlafaxine does not support this theory. I believe, therefore, that Figure 3 and the discussion are somewhat misleading in that the data do not indicate a greater likelihood for venlafaxine to cause switches. Rather, the data suggest that venlafaxine is less likely to cause subthreshold switches, which is probably not a meaningful finding.

Reference

  1. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM: Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006; 163:232–239[Abstract/Free Full Text]




This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by MATTES, J. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by MATTES, J. A.
Related Collections
* Other Mood Disorders
* Antidepressants


Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org